Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Anticomplement therapy.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Potential therapeutic benefit of c1-esterase inhibitor in neuromyelitis optica evaluated in vitro and in an experimental rat model.
Carboxypeptidase N-deficient mice present with polymorphic disease phenotypes on induction of experimental autoimmune encephalomyelitis.
Roles for HB-EGF and CD9 in multiple sclerosis.
Demyelination complicating anti-tnf therapy in inflammatory bowel disease (ibd) and other inflammatory disorders (pred4-ukcrn 11988).
Diffusion-weighted imaging and demyelinating diseases: new aspects of an old advanced sequence.
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Repair strategies for multiple sclerosis: challenges, achievements and perspectives.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
A case of multiple sclerosis and celiac disease.
[Demyelinating process in systematic rheumatoid diseases (review)].
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Saffold cardiovirus and multiple sclerosis: no evidence for an association.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
Neurofascin 140 is an embryonic neuronal neurofascin isoform that promotes the assembly of the node of ranvier.
Correction: Cerebral Circulation Time is Prolonged and Not Correlated with EDSS in Multiple Sclerosis Patients: A Study Using Digital Subtracted Angiography.
Fingolimod first-dose effects in patients with relapsing multiple sclerosis concomitantly receiving selective serotonin-reuptake inhibitors.
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.
Poster Abstracts from the Fourth International Symposium on Gait and Balance in Multiple Sclerosis: The Role of CognitionCleveland Clinic • Cleveland, Ohio, USA • October 10 & 11, 2014.
Using multiple imputation to efficiently correct cerebral MRI whole brain lesion and atrophy data in patients with multiple sclerosis.
Transplanting of Mesenchymal Stem Cells May Affect Proliferation and Function of CD4+T Cells in Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
474
475
476
477
478
479
480
481
482
…
next ›
last »